BioSpace News Archive

Biotech Bay

Gynesonics Announces Full Launch of New Sonata 2 System at 48th AAGL Global Congress

2-year Outcomes Data from the SONATA IDE Pivotal Trial To Be Presented, Demonstrating Significant and Sustained Symptom Relief

November 11, 2019
·
6 min read
Deals

Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications

Combination establishes a dermatology-focused company with a broad portfolio of an approved product and late-stage dermatology assets

November 11, 2019
·
19 min read
Drug Development

Cerecor Announces Clinical Updates on CERC-301 and CERC-802

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan diseases and neurology, announced today that it has achieved significant milestones in its clinical development programs.

November 11, 2019
·
12 min read
Job Trends

Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening

Clinical Study Shows Prequel Delivers an Industry Leading Low Test Failure Rate of 0.1%

November 11, 2019
·
7 min read
Business

Neptune Reports Fiscal 2020 Second Quarter Results

Neptune Wellness Solutions Inc. (“Neptune” or the “Corporation”) (NASDAQ: NEPT) (TSX: NEPT), today announced its financial and operating results for the three-month period ended September 30, 2019.

November 11, 2019
·
22 min read
Zimmer Biomet Holdings to Present at Piper Jaffray’s 31st Annual Healthcare Conference

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace in New York City.

November 11, 2019
·
1 min read
Business

Compugen Reports Third Quarter 2019 Results

Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the third quarter ended September 30, 2019.

November 11, 2019
·
9 min read
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system

AI Medical Service Inc., one of the world’s first real-time endoscopic artificial intelligence (AI) developers, today announced the Company has secured Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer.

November 11, 2019
·
2 min read